Prognostic value of chromogranin A in chronic heart failure: data from the GISSI-Heart Failure trial (Q33554096)

28 July 2017

Prognostic value of chromogranin A in chronic heart failure: data from the GISSI-Heart Failure trial (English)

1 reference

28 July 2017

0 references

chronic heart failure

1 reference

4

Allan Flyvbjerg

1 reference

28 July 2017

Valentina Milani

5

0 references

Miriam Revera

object named as

Miriam Revera

7

0 references

Alessandro Mezzani

object named as

Alessandro Mezzani

8

0 references

Luigi Tavazzi

10

object named as

Luigi Tavazzi

1 reference

28 July 2017

11

Torbjørn Omland

1 reference

28 July 2017

1

Helge Røsjø

1 reference

28 July 2017

Serge Masson

2

1 reference

28 July 2017

Roberto Latini

3

1 reference

28 July 2017

Maria Teresa La Rovere

6

1 reference

28 July 2017

Gianni Tognoni

9

1 reference

28 July 2017

GISSI-HF Investigators

12

1 reference

28 July 2017

language of work or name

1 reference

13 April 2010

1 reference

European Journal of Heart Failure

28 July 2017

1 reference

28 July 2017

12

1 reference

28 July 2017

6

1 reference

28 July 2017

549-556

1 reference

The chromogranin-secretogranin family

28 July 2017

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ055

Association between plasma chromogranin A concentration and long-term mortality after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ055

Prognostic value of circulating chromogranin A levels in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ055

Chromogranin A and C-terminal endothelin-1 precursor fragment add independent prognostic information to amino-terminal proBNP in patients with acute destabilized heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ055

Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ055

Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ055

Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ055

Relationship between renal function and blood level of chromogranin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ055

Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ055

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ055

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ055

Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ055

Chromogranin A correlates with norepinephrine release rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ055

Clinical, hemodynamic and sympathetic neural correlates of heart rate variability in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ055

The chromogranin A-derived peptides vasostatin-I and catestatin as regulatory peptides for cardiovascular functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ055

Chromogranin A regulates renal function by triggering Weibel-Palade body exocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ055

Different spectral components of 24 h heart rate variability are related to different modes of death in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ055

Heart rate variability: Standards of measurement, physiological interpretation, and clinical use

21 January 2018

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/OXFORDJOURNALS.EURHEARTJ.A014868

Identifiers

DOI

10.1093/EURJHF/HFQ055

1 reference

28 July 2017

1 reference